200 related articles for article (PubMed ID: 16143789)
1. Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
Meigooni AS; Awan SB; Rachabatthula V; Koona RA
J Appl Clin Med Phys; 2005; 6(3):23-36. PubMed ID: 16143789
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
5. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
Meigooni AS; Luerman CM; Sowards KT
Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
10. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Li XA; Wang JZ; Stewart RD; DiBiase SJ
Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
[TBL] [Abstract][Full Text] [Related]
11. Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.
Awan SB; Dini SA; Hussain M; Soleimani-Meigooni D; Meigooni AS
J Appl Clin Med Phys; 2008 Apr; 9(2):123-142. PubMed ID: 18714281
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
Sowards KT
J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric study of a new polymer encapsulated palladium-103 seed.
Bernard S; Vynckier S
Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
15. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
16. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
17. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Yue N; Chen Z; Nath R
Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
[TBL] [Abstract][Full Text] [Related]
18. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
Sadeghi M; Raisali G; Hosseini SH; Shavar A
Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
[TBL] [Abstract][Full Text] [Related]
20. Prescription dose in permanent (131)Cs seed prostate implants.
Yue N; Heron DE; Komanduri K; Huq MS
Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]